{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:18:43Z","timestamp":1783297123412,"version":"3.54.6"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/mp.2013.142","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T08:58:44Z","timestamp":1383037124000},"page":"1125-1132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The SORL1 gene and convergent neural risk for Alzheimer\u2019s disease across the human lifespan"],"prefix":"10.1038","volume":"19","author":[{"given":"D","family":"Felsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Szeszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W G","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Lobaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B H","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B G","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A N","family":"Voineskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"BFmp2013142_CR1","unstructured":"Prince M, Jackson J Alzheimer\u2019s Disease International World Alzheimer Report 2009. Alzheimer\u2019s Disease International, 2009 (cited 2012). Available fromhttp:\/\/www.alz.co.uk\/research\/files\/WorldAlzheimerReport.pdf."},{"key":"BFmp2013142_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S1474-4422(12)70256-9","volume":"11","author":"N Fox","year":"2012","unstructured":"Fox N . When, where, and how does Alzheimer\u2019s disease start? Lancet Neurol 2012; 11: 1017\u20131018.","journal-title":"Lancet Neurol"},{"key":"BFmp2013142_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","volume":"11","author":"EM Reiman","year":"2012","unstructured":"Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol 2012; 11: 1048\u20131056.","journal-title":"Lancet Neurol"},{"key":"BFmp2013142_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2217\/bmm.09.91","volume":"4","author":"EM Reiman","year":"2010","unstructured":"Reiman EM, Langbaum JBS, Tariot PN . Alzheimer\u2019s prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med 2010; 4: 3\u201314.","journal-title":"Biomark Med"},{"key":"BFmp2013142_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jamapsychiatry.2013.865","volume":"70","author":"D Felsky","year":"2013","unstructured":"Felsky D, Voineskos AN . APoe \u03b5 4, aging, and effects on white matter across the adult life span. JAMA Psychiatry 2013; 70: 646\u2013647.","journal-title":"JAMA Psychiatry"},{"key":"BFmp2013142_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neurobiolaging.2010.03.009","volume":"33","author":"AJ Trachtenberg","year":"2012","unstructured":"Trachtenberg AJ, Filippini N, Mackay CE . The effects of APOE-\u025b4 on the BOLD response. Neurobiol Aging 2012; 33: 323\u2013334.","journal-title":"Neurobiol Aging"},{"key":"BFmp2013142_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","volume":"107","author":"L Bertram","year":"2012","unstructured":"Bertram L, Tanzi RE . The genetics of Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 2012; 107: 79\u2013100.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"BFmp2013142_CR8","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/j.1471-4159.2008.05517.x","volume":"106","author":"H-S Hoe","year":"2008","unstructured":"Hoe H-S, Rebeck GW . Functional interactions of APP with the apoE receptor family. J Neurochem 2008; 106: 2263\u20132271.","journal-title":"J Neurochem"},{"key":"BFmp2013142_CR9","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1073\/pnas.0503689102","volume":"102","author":"OM Andersen","year":"2005","unstructured":"Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J et al. Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2005; 102: 13461\u201313466.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2013142_CR10","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1523\/JNEUROSCI.4946-05.2006","volume":"26","author":"K Offe","year":"2006","unstructured":"Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI et al. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 2006; 26: 1596\u20131603.","journal-title":"J Neurosci"},{"key":"BFmp2013142_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3233\/JAD-2012-121399","volume":"33","author":"S Capsoni","year":"2012","unstructured":"Capsoni S, Carlo A-S, Vignone D, Amato G, Criscuolo C, Willnow TE et al. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 2012; 33: 357\u2013371.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2013142_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1242\/jcs.072538","volume":"124","author":"SC Klinger","year":"2011","unstructured":"Klinger SC, Glerup S, Raarup MK, Mari MC, Nyegaard M, Koster G et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sci 2011; 124: 1095\u20131105.","journal-title":"J Cell Sci"},{"key":"BFmp2013142_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s11910-008-0060-8","volume":"8","author":"JH Lee","year":"2008","unstructured":"Lee JH, Barral S, Reitz C . The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer\u2019s disease. Curr Neurol Neurosci Rep 2008; 8: 384\u2013391.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BFmp2013142_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1001\/archneurol.2010.346","volume":"68","author":"C Reitz","year":"2011","unstructured":"Reitz C, Cheng R, Rogaeva E, Lee JH, Tokuhiro S, Zou F et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol 2011; 68: 99\u2013106.","journal-title":"Arch Neurol"},{"key":"BFmp2013142_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39: 168\u2013177.","journal-title":"Nat Genet"},{"key":"BFmp2013142_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"C Pottier","year":"2012","unstructured":"Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatr 2012; 17: 875\u2013879.","journal-title":"Mol Psychiatr"},{"key":"BFmp2013142_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneurol.2011.788","volume":"69","author":"S Caglayan","year":"2012","unstructured":"Caglayan S, Bauerfeind A, Schmidt V, Carlo A-S, Prabakaran T, H\u00fcbner N et al. Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. Arch Neurol 2012; 69: 373\u2013379.","journal-title":"Arch Neurol"},{"key":"BFmp2013142_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1326-4-46","volume":"4","author":"KE Grear","year":"2009","unstructured":"Grear KE, Ling I-F, Simpson JF, Furman JL, Simmons CR, Peterson SL et al. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener 2009; 4: 46.","journal-title":"Mol Neurodegener"},{"key":"BFmp2013142_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ana.21190","volume":"62","author":"KL Sager","year":"2007","unstructured":"Sager KL, Wuu J, Leurgans SE, Rees HD, Gearing M, Mufson EJ et al. Neuronal LR11\/sorLA expression is reduced in mild cognitive impairment. Ann Neurol 2007; 62: 640\u2013647.","journal-title":"Ann Neurol"},{"key":"BFmp2013142_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/archneur.61.8.1200","volume":"61","author":"CR Scherzer","year":"2004","unstructured":"Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 2004; 61: 1200\u20131205.","journal-title":"Arch Neurol"},{"key":"BFmp2013142_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archneur.65.12.1640","volume":"65","author":"KT Cuenco","year":"2008","unstructured":"Cuenco KT, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA et al. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol 2008; 65: 1640\u20131648.","journal-title":"Arch Neurol"},{"key":"BFmp2013142_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1176\/appi.ajp.2011.10101509","volume":"168","author":"J Bralten","year":"2011","unstructured":"Bralten J, Arias-V\u00e1squez A, Makkinje R, Veltman JA, Brunner HG, Fern\u00e1ndez G et al. Association of the Alzheimer\u2019s gene SORL1 with hippocampal volume in young, healthy adults. Am J Psychiatry 2011; 168: 1083\u20131089.","journal-title":"Am J Psychiatry"},{"key":"BFmp2013142_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1212\/WNL.0b013e3182661f4d","volume":"79","author":"L Zhuang","year":"2012","unstructured":"Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, Brodaty H et al. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 2012; 79: 748\u2013754.","journal-title":"Neurology"},{"key":"BFmp2013142_CR24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR . \u2018Mini-mental state\u2019. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189\u2013198.","journal-title":"J Psychiatr Res"},{"key":"BFmp2013142_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neuroimage.2008.12.028","volume":"45","author":"AN Voineskos","year":"2009","unstructured":"Voineskos AN, O\u2019Donnell LJ, Lobaugh NJ, Markant D, Ameis SH, Niethammer M et al. Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage 2009; 45: 370\u2013376.","journal-title":"Neuroimage"},{"key":"BFmp2013142_CR26","first-page":"646","volume":"70","author":"D Felsky","year":"2013","unstructured":"Felsky D, Voineskos AN . APOE \u025b4, aging, and effects on white matter across the adult lifespan. Arch Gen Psychiatry 2013; 70: 646\u2013647.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2013142_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fpsyt.2012.00040","volume":"3","author":"D Felsky","year":"2012","unstructured":"Felsky D, Voineskos AN, Lerch JP, Nazeri A, Shaikh SA, Rajji TK et al. Myelin-associated glycoprotein gene and brain morphometry in schizophrenia. Front Psychiatry 2012; 3: 40.","journal-title":"Front Psychiatry"},{"key":"BFmp2013142_CR28","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/cercor\/bhp280","volume":"20","author":"LT Westlye","year":"2010","unstructured":"Westlye LT, Walhovd KB, Dale AM, Bj\u00f8rnerud A, Due-T\u00f8nnessen P, Engvig A et al. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex 2010; 20: 2055\u20132068.","journal-title":"Cereb Cortex"},{"key":"BFmp2013142_CR29","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/schbul\/sbs054","volume":"38","author":"BD Peters","year":"2012","unstructured":"Peters BD, Szeszko PR, Radua J, Ikuta T, Gruner P, DeRosse P et al. White matter development in adolescence: diffusion tensor imaging and meta-analytic results. Schizophr Bull 2012; 38: 1308\u20131317.","journal-title":"Schizophr Bull"},{"key":"BFmp2013142_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"36","author":"J Kaufman","year":"1997","unstructured":"Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980\u2013988.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFmp2013142_CR31","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition. (SCID-I\/NP) 2002."},{"key":"BFmp2013142_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.biopsych.2006.06.019","volume":"60","author":"BK Lipska","year":"2006","unstructured":"Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biological Psychiatry 2006; 60: 650\u2013658.","journal-title":"Biological Psychiatry"},{"key":"BFmp2013142_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10524","volume":"478","author":"C Colantuoni","year":"2011","unstructured":"Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519\u2013523.","journal-title":"Nature"},{"key":"BFmp2013142_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS . Overview and findings from the religious orders study. Curr Alzheimer Res 2012; 9: 628\u2013645.","journal-title":"Curr Alzheimer Res"},{"key":"BFmp2013142_CR35","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/156720512801322663","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS . Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 2012; 9: 646\u2013663.","journal-title":"Curr Alzheimer Res"},{"key":"BFmp2013142_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF et al. Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006; 27: 169\u2013176.","journal-title":"Neuroepidemiology"},{"key":"BFmp2013142_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.23654","volume":"72","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA . Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol 2012; 72: 599\u2013609.","journal-title":"Ann Neurol"},{"key":"BFmp2013142_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22277","volume":"69","author":"LB Chibnik","year":"2011","unstructured":"Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D et al. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol 2011; 69: 560\u2013569.","journal-title":"Ann Neurol"},{"key":"BFmp2013142_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-7-3","volume":"7","author":"A Schroeder","year":"2006","unstructured":"Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3.","journal-title":"BMC Mol Biol"},{"key":"BFmp2013142_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neulet.2009.06.014","volume":"461","author":"R Kimura","year":"2009","unstructured":"Kimura R, Yamamoto M, Morihara T, Akatsu H, Kudo T, Kamino K et al. SORL1 is genetically associated with Alzheimer disease in a Japanese population. Neurosci Lett 2009; 461: 177\u2013180.","journal-title":"Neurosci Lett"},{"key":"BFmp2013142_CR41","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.neurobiolaging.2007.10.013","volume":"30","author":"EK Tan","year":"2009","unstructured":"Tan EK, Lee J, Chen CP, Teo YY, Zhao Y, Lee WL . SORL1 haplotypes modulate risk of Alzheimer\u2019s disease in Chinese. Neurobiol Aging 2009; 30: 1048\u20131051.","journal-title":"Neurobiol Aging"},{"key":"BFmp2013142_CR42","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/mp.2008.141","volume":"15","author":"TM Feulner","year":"2010","unstructured":"Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SHR, Riehle C et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 2010; 15: 756\u2013766.","journal-title":"Mol Psychiatry"},{"key":"BFmp2013142_CR43","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/WNR.0b013e3282f13e7a","volume":"18","author":"Y Meng","year":"2007","unstructured":"Meng Y, Lee JH, Cheng R St, George-Hyslop P, Mayeux R, Farrer LA . Association between SORL1 and Alzheimer\u2019s disease in a genome-wide study. Neuroreport 2007; 18: 1761\u20131764.","journal-title":"Neuroreport"},{"key":"BFmp2013142_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2796.2004.01381.x","volume":"256","author":"MJ De Leon","year":"2004","unstructured":"De Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S et al. MRI and CSF studies in the early diagnosis of Alzheimer\u2019s disease. J Intern Med 2004; 256: 205\u2013223.","journal-title":"J Intern Med"},{"key":"BFmp2013142_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","volume":"62","author":"CR Jack Jr","year":"2004","unstructured":"Jack CR Jr, Shiung MM, Gunter JL, O\u2019Brien PC, Weigand SD, Knopman DS et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004; 62: 591\u2013600.","journal-title":"Neurology"},{"key":"BFmp2013142_CR46","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuroimage.2004.07.006","volume":"23","author":"GB Karas","year":"2004","unstructured":"Karas GB, Scheltens P, Rombouts SARB, Visser PJ, van Schijndel RA, Fox NC et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer\u2019s disease. Neuroimage 2004; 23: 708\u2013716.","journal-title":"Neuroimage"},{"key":"BFmp2013142_CR47","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.neurobiolaging.2011.06.027","volume":"33","author":"H Huang","year":"2012","unstructured":"Huang H, Fan X, Weiner M, Martin-Cook K, Xiao G, Davis J et al. Distinctive disruption patterns of white matter tracts in Alzheimer\u2019s disease with full diffusion tensor characterization. Neurobiology Aging 2012; 33: 2029\u20132045.","journal-title":"Neurobiology Aging"},{"key":"BFmp2013142_CR48","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/hbm.20978","volume":"31","author":"M Pievani","year":"2010","unstructured":"Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M et al. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer\u2019s disease. Hum Brain Map 2010; 31: 1862\u20131875.","journal-title":"Hum Brain Map"},{"key":"BFmp2013142_CR49","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/brain\/awp071","volume":"132","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Schuff N, Du A-T, Rosen HJ, Kramer JH, Gorno-Tempini ML et al. White matter damage in frontotemporal dementia and Alzheimer\u2019s disease measured by diffusion MRI. Brain 2009; 132: 2579\u20132592.","journal-title":"Brain"},{"key":"BFmp2013142_CR50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1212\/WNL.0b013e3182662020","volume":"79","author":"OT Carmichael","year":"2012","unstructured":"Carmichael OT, Salloway S . Imaging markers of incipient dementia The white matter matters. Neurology 2012; 79: 726\u2013727.","journal-title":"Neurology"},{"key":"BFmp2013142_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1552-6569.2006.00047.x","volume":"16","author":"RO Hopkins","year":"2006","unstructured":"Hopkins RO, Beck CJ, Burnett DL, Weaver LK, Victoroff J, Bigler ED . Prevalence of white matter hyperintensities in a young healthy population. J Neuroimag 2006; 16: 243\u2013251.","journal-title":"J Neuroimag"},{"key":"BFmp2013142_CR52","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.neurobiolaging.2010.10.004","volume":"33","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ, Saith S, Linnertz C, Burke JR, Hulette CM, Welsh-Bohmer KA et al. The Alzheimer\u2019s associated 5\u2019 region of the SORL1 gene cis regulates SORL1 transcripts expression. Neurobiol Aging 2012; 33: 1485, e1\u20138.","journal-title":"Neurobiol Aging"},{"key":"BFmp2013142_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/emboj.2011.352","volume":"31","author":"V Schmidt","year":"2012","unstructured":"Schmidt V, Baum K, Lao A, Rateitschak K, Schmitz Y, Teichmann A et al. Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer\u2019s disease. EMBO J 2012; 31: 187\u2013200.","journal-title":"EMBO J"},{"key":"BFmp2013142_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/archneurol.2009.22","volume":"66","author":"Q-L Ma","year":"2009","unstructured":"Ma Q-L, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J et al. Reduction of SorLA\/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 2009; 66: 448\u2013457.","journal-title":"Arch Neurol"},{"key":"BFmp2013142_CR55","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/01.jnen.0000228205.19915.20","volume":"65","author":"SE Dodson","year":"2006","unstructured":"Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ . LR11\/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 866\u2013872.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFmp2013142_CR56","doi-asserted-by":"publisher","first-page":"e1001101","DOI":"10.1371\/journal.pgen.1001101","volume":"6","author":"C Cruchaga","year":"2010","unstructured":"Cruchaga C, Kauwe JSK, Mayo K, Spiegel N, Bertelsen S, Nowotny P et al. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer\u2019s disease. PLoS Genet 2010; 6: e1001101.","journal-title":"PLoS Genet"},{"key":"BFmp2013142_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JAD-2011-110983","volume":"28","author":"P Alexopoulos","year":"2012","unstructured":"Alexopoulos P, Guo L-H, Tsolakidou A, Kratzer M, Grimmer T, Westerteicher C et al. Interrelations between CSF soluble A\u03b2PP\u03b2, amyloid-\u03b2 1-42, SORL1, and tau levels in Alzheimer\u2019s disease. J Alzheimers Dis 2012; 28: 543\u2013552.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2013142_CR58","doi-asserted-by":"publisher","first-page":"e37720","DOI":"10.1371\/journal.pone.0037720","volume":"7","author":"BB Bendlin","year":"2012","unstructured":"Bendlin BB, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Willette AA et al. CSF T-Tau\/A\u03b242 predicts white matter microstructure in healthy adults at risk for Alzheimer\u2019s disease. PLoS One 2012; 7: e37720.","journal-title":"PLoS One"},{"key":"BFmp2013142_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/RMR.0b013e3181809f1e","volume":"19","author":"T White","year":"2008","unstructured":"White T, Nelson M, Lim KO . Diffusion tensor imaging in psychiatric disorders. Top Magn Reson Imaging 2008; 19: 97\u2013109.","journal-title":"Top Magn Reson Imaging"},{"key":"BFmp2013142_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1212\/01.wnl.0000250326.77323.01","volume":"68","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Schuff N, Jahng G-H, Bayne W, Mori S, Schad L et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007; 68: 13\u201319.","journal-title":"Neurology"},{"key":"BFmp2013142_CR61","doi-asserted-by":"publisher","unstructured":"Larroza A, Moratal D, D\u2019oc\u00f3n Alca\u00f1iz V, Arana E . por la Alzheimer\u2019s Disease Neuroimaging Initiative. Tractography of the uncinate fasciculus and the posterior cingulate fasciculus in patients with mild cognitive impairment and Alzheimer disease. Neurologia, advance online publication, 10 April 2013; pii: S0213-4853(13)00022-4; doi:10.1016\/j.nrl.2013.02.002 (e-pub ahead of print).","DOI":"10.1016\/j.nrl.2013.02.002"},{"key":"BFmp2013142_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1479-8301.2010.00312.x","volume":"10","author":"M Morikawa","year":"2010","unstructured":"Morikawa M, Kiuchi K, Taoka T, Nagauchi K, Kichikawa K, Kishimoto T . Uncinate fasciculus-correlated cognition in Alzheimer\u2019s disease: a diffusion tensor imaging study by tractography. Psychogeriatrics 2010; 10: 15\u201320.","journal-title":"Psychogeriatrics"},{"key":"BFmp2013142_CR63","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jocn.2012.09.025","volume":"20","author":"J-H Wang","year":"2013","unstructured":"Wang J-H, Lv P-Y, Wang H-B, Li Z-L, Li N, Sun Z-Y et al. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer\u2019s disease. J Clin Neurosci 2013; 20: 1089\u20131094.","journal-title":"J Clin Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2013142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2013142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:46:24Z","timestamp":1648781184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2013142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFmp2013142"],"URL":"https:\/\/doi.org\/10.1038\/mp.2013.142","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]},"assertion":[{"value":"2 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Within the past 5 years, BGP has been a member of the advisory board of Lundbeck Canada (final meeting was May 2009) and Forest Laboratories (final meeting was March 2008). He has also served one time as a consultant for Wyeth (October 2008) and Takeda (July 2007) and was a faculty member of the Lundbeck International Neuroscience Foundation (LINF) (final meeting was April 2010). JLK has been a consultant to GlaxoSmithKline, Sanofi-Aventis and Dianippon-Sumitomo. BHM has received travel support from Roche. AKM has served as a consultant for Genomind Inc. All other authors declare no conflict of interest. ANV had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}